Table 1 |
||||||
|
Literature review of Posttransplant lymphoproliferative disorders (PTLD) arsing in the oral cavity |
||||||
|
Author |
Age & sex, site |
Onset |
Diagnosis, site |
EBV status |
Treatment |
Follow up |
|
|
||||||
|
Doak et al 1968 |
34 ♂, kidney |
180 days |
Reticular Cell Sarcoma, tongue & oral cavity |
Viral inclusions |
Antimycotic Medication NOS |
Died 30 days after |
|
Staddlemann et al 1996 |
65 ♀, kidney |
600 days |
NK/T-cell lymphoma, pharynx |
Positive |
Cyclosporine d/c, Four cycles CHOP |
Remission for 1080 days |
|
Reams et al 2003 |
16 ♀, R + L lung |
330 days |
Polymorphic B-cell lymphoma, tongue |
Negative |
Four cycles of Rituximab |
Patient died of Sepsis |
|
Rolland et al 2004 |
60 ♂, heart |
3600 days |
Peripheral T-cell lymphoma NOS, gingiva |
Positive |
Azathioprine d/c, decrease Cyclosporin |
Remission for 360 days |
|
Rolland et al 2004 |
61 ♂, heart |
1410 days |
DLBCL, maxilla |
Posotive |
Stepwise decrease in Ciclosporin |
Recurrences at 180 and 510 days |
|
Bruce et al 2006 |
45 ♀, pancreas |
660 days |
DLBCL, tongue |
Positive |
Sirolimus d/c Tacrolimus adjusted |
Remission 660 days, AR |
|
Gonzalez-Cuyar et al 2007 |
47, ♂, kidney pancreas |
720 days |
DLBCL, tongue |
Positive |
Decreased immunosupression |
Remission for 790 days |
|
|
||||||
|
Gonzalez-Cuyar et al. Diagnostic Pathology 2007 2:49 doi:10.1186/1746-1596-2-49 |
||||||
